Consistent with the previous clinical studies, the virtual CPVI had effective anti-AF effects regardless of the PITX2 genotype, whereas virtual AADs exhibited more significant defragmentation or wave-dynamic changes in the PITX2+/− deficient genotype. This evidence concerns the gene PITX2 and atrial fibrillation.